Effects of FKBP-12 ligands following tibial nerve injury in rats

Journal of Reconstructive Microsurgery

Volumn 16, Issue 8, 2000, Pages 613-620

  Becker, D B ^a   Jensen, J N ^a   Myckatyn, T M ^a   Doolabh, V B ^a   Hunter, D A ^a   Mackinnon, S E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALCINEURIN; FK 506 BINDING PROTEIN; FKBP 12 LIGAND; IMMUNOPHILIN; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; GAIT; MORPHOMETRICS; NERVE INJURY; NERVE REGENERATION; NERVE TRANSECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TIBIAL NERVE;

ANIMALS; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; PYRIDINES; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; TACROLIMUS; TACROLIMUS BINDING PROTEIN 1A; TIBIAL NERVE;

EID: 0033646279     PISSN: 0743684X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. The effect of duration of muscle denervation on functional recovery in the rat model
2. FK506 and Cyclosporin A promote functional recovery in crushed rat sciatic nerve
3. Peripheral nerve allograft transplantation with FK506: Functional, histological, and immunological results before and after discontinuation of immunosuppression Ann Plast Surg
4. The immunosuppressant FK506 increases functional recovery and nerve re generation following peripheral nerve injury
5. FK506 accelerates functional recovery following nerve grafting in a rat model
6. Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice
7. Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat
8. Hyaluronic acid through a new injectable nerve guide delivery system enhances peripheral nerve regeneration in the rat
9. Neuromuscular recovery after peripheral nerve repair: Effects of an orally-administered peptide in a primate model
10. Topical GM1 ganglioside to promote crushed rat sciatic nerve regeneration
11. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve
12. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin
13. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
14. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin, and cyclosporin A
15. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neuroregenerative animal models
16. The mechanism of action of cyclosporin A and FK506
17. Neuronal regeneration enhances the expression of the immunophilin FKBP-12
18. Acceleration of peripheral nerve regeneration following FK506 administration
19. The effect of the immunosuppressant FK506 on peripheral nerve regeneration following nerve grafting
20. Peripheral nerve allotransplant immunosuppressed with FK506: Preliminary results
21. Peripheral-nerve allotransplantation in rats immunosuppressed with transient or long-term FK-506
22. FK506 rescues peripheral nerve allografts in acute rejection
23. Comparative dose-dependent study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve
24. A novel immunophilin ligand: Distinct branching effect on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease
25. FK506 and the role of immunophilins in nerve regeneration
26. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration
27. Oral administration of a nonimmunosuppressant FKBP-12 ligand speeds nerve regeneration
28. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats
29. Nerve crush injuries - A model for axonotmesis
30. Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat
31. Inter- and intraobserver reliability of walking-track analysis used to assess sciatic nerve function in rats
32. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks
33. Walking track analysis: A long-term assessment of peripheral nerve recovery
34. FK506, a novel immunosuppressant isolated from Streptomyces. II. Immunosuppressive effect of FK506 in vitro
35. Effect of FK506 in experimental organ transplantation
36. FK506 for liver, kidney, and pancreas transplantation
37. Small intestinal transplantation in humans with or without the colon
38. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation
39. Immunosuppressive strategies in transplantation
40. A randomized trial of primary liver transplantation under immunosuppression with FK506 vs. Cyclosporine
41. The side-effects of cyclosporine-A and tacrolimus
42. Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats
43. Tacrolimus, a new immunosuppressant - A review of the literature
44. Design, synthesis, and structure of non-macrocyclic inhibitors of FKBP-12, the major binding protein for the immunosuppressant FK506
45. Timcodar dimesylate and other neurophilin ligands improve outcome in the Streptozotocin rat model of diabetic neuropathy
46. Sciatic function index, nerve conduction tests, muscle contraction, and axon morphometry as indicators of regeneration
47. Lack of association between outcome measures of nerve regeneration
48. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506
49. Regulation of calcineurin by growth cone calcium waves controls neurite extension